OneCell Diagnostics bags $16M to help limit cancer reoccurrence using AI
OneCell Diagnostics has secured $16 million in a Series A round as it aims to limit cancer recurrence using AI advancements ...
American Lung Association3h
New Report: Lung Cancer Survival Rate Improves, But Gaps in Biomarker Testing and Lack of Screening Hinder Progress
American Lung Association’s ‘State of Lung Cancer’ report reveals stark differences in survival, screening and treatment across states ...
McKnight's Long-Term Care News4h
American Lung Association uncovers stark differences in lung cancer survival, screening and treatment across states
A new report from the American Lung Association reveals both progress and persistent challenges in the fight against lung ...
Channel 300010h
Facing terminal cancer, former flight attendant granted final wish to fly one last time
A special last wish was granted for a Calaveras County hospice patient facing a daunting diagnosis. Janet McAnnally, 79, was ...
More people surviving lung cancer, but work remains in screening and biomarker testing
The lung cancer survival rate has improved 26% in the last five years, according to the American Lung Association’s ...
The Conway Daily Sun11h
N.H. ahead in lung cancer survival, diagnosis and treatment
Lung cancer is the leading cause of cancer deaths in New Hampshire and across the U.S., but the American Lung Association’s 2024 State of Lung Cancer report indicates ...
The Times of Northwest Indiana18h
Get Healthy: Medical Report: Early detection, advanced technologies key to positive lung cancer outcomes
The good news is, with advanced medical technologies, physicians now are better able to discover and treat diseases in their ...
Alpha Biopharma received NMPA approval for Zorifertinib Tablets (Zorifer®), the world's first EGFR-TKI for lung cancer with brain metastases.
On November 20, 2024, the National Medical Products Administration (NMPA) announced on its official website that the NMPA approved the listing of Zorifertinib Hydrochloride Tablets (trade name: ...
NOLA.com18h
Lung cancer survival in Louisiana among worst in U.S., but new treatments can help
Louisiana residents have one of the highest lung cancer death rates in the country, even as groundbreaking treatments in ...
Metastatic Colorectal Cancer Market Forecast to Reach US$ 9,787.5 Million by 2034, Growing at 5.1% CAGR | Fact.MR Report
Global Metastatic Colorectal Cancer Market to Record Stellar Growth with Advancements in Treatments and Rise in Healthcare InfrastructuresRockville, MD, Nov. 20, 2024 (GLOBE NEWSWIRE) -- According to ...